Intake of copper has no effect on cognition in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial

Disturbed copper (Cu) homeostasis may be associated with the pathological processes in Alzheimer’s disease (AD). In the present report, we evaluated the efficacy of oral Cu supplementation in the treatment of AD in a prospective, randomized, double-blind, placebo-controlled phase 2 clinical trial in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kessler, Holger, Bayer, Thomas A., Bach, Daniela, Schneider-Axmann, Thomas, Supprian, Tillmann, Herrmann, Wolfgang, Haber, Manfred, Multhaup, Gerd, Falkai, Peter, Pajonk, Frank-Gerald
Formato: Artigo
Idioma:Inglês
Publicado: Springer Vienna 2008
Assuntos:
Alzheimer's Disease and Related Disorders - Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2516533/
https://ncbi.nlm.nih.gov/pubmed/18587525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00702-008-0080-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares